Fasting in the ICU: a metabolic key to immune response?

NCT ID NCT07738536

First seen Jul 31, 2026 ยท Last updated Jul 31, 2026

Summary

This study investigates what happens when critically ill patients in the intensive care unit (ICU) are not given nutrition for the first 72 hours after admission. Researchers will measure ketone bodies in the blood and examine how immune cells respond, comparing these patients to those receiving standard care. The goal is to understand whether short-term fasting induces ketosis and alters immune function in critical illness, which could inform future nutrition strategies in the ICU.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
Delayed nutrition (withholding enteral/parenteral nutrition and glucose solutions for the first 72 hours in the ICU)
What this could lead to
If this trial succeeds, it could reveal whether short-term fasting in critically ill patients is safe and beneficial, potentially guiding ICU nutrition practices to improve recovery.
What could go wrong
This is an early-stage substudy focused on biological markers, not clinical outcomes. Results may not translate to better patient outcomes, and fasting could pose risks in some critically ill patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Critical Illness Fasting Ketosis nutritional disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Karolinska University Hospital Huddinge

    Stockholm, 14186, Sweden

More trials for these conditions

Other studies related to the condition(s) this trial covers.